Filing Details

Accession Number:
0000899243-18-016285
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-12 20:26:30
Reporting Period:
2018-06-08
Accepted Time:
2018-06-12 20:26:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1160308 Savara Inc SVRA Pharmaceutical Preparations (2834) 841318182
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1408498 L David Lowrance 6836 Bee Cave Road, Building Iii
Suite 200
Austin TX 78746
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-06-08 675 $12.13 23,080 No 4 S Direct
Common Stock Disposition 2018-06-11 700 $12.05 22,380 No 4 S Direct
Common Stock Disposition 2018-06-12 3,900 $12.08 18,480 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017.
  2. The price is a weighted average sale price. The sale prices ranged from $12.00 to $12.40. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  3. The price is a weighted average sale price. The sale prices ranged from $12.00 to $12.2575. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  4. The price is a weighted average sale price. The sale prices ranged from $12.00 to $12.23. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.